Logo

Eppendorf Licenses Gradient Tech for Thermal Cyclers to SensoQuest

Sep 15, 2014 | staff reporter

NEW YORK (GenomeWeb) — Eppendorf said today that it has licensed patents covering gradient technology for thermal cyclers to SensoQuest, including German patent Nos. DE 19655282 and DE 19655141.

SensoQuest, based in Göttingen, Germany, is a privately held firm specializing in thermocyclers.

Financial terms of the agreement were not disclosed.

Eppendorf uses the gradient technology in its Mastercycler Pro Gradient and Mastercycler Nexus Gradient thermal cyclers, but has licensed the technology out to a number of companies, including Peqlab, Agilent Technologies, and Bulldog Bio.

Filed under

PCR
thermal cycler
Eppendorf
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.